Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo

Effect of Controlled Ovarian Stimulation With H FSH and HHMg Vs HMG Alone on Oocyte and Embryo Quality in IcsI Patients

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04539067

Enrollment

Registered

2020-09-04

Start date

2020-09-01

Completion date

2021-10-31

Last updated

2020-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Stimulation

Brief summary

Investigate and compare the efficacy of H FSH plus HMG Vs HMG alone on oocyte and embryo quality in IcsI patients

Detailed description

70 patients divided in to 2groups Group A controlled ovarian stimulation with H FSH and HHMg Group B controlled ovarian stimulation with HMG alone Results will be discussed later

Interventions

DRUGHHMG

Induction of ovulation from the 2nd day of cycle to 5th day then follow the diameter of follicle Use transvaginal ultrasound When diameter of follicle 18 to 22 patients receiving HMG

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

1. Infertil women aged from 20\_35yr 2. Normal utreus 3. Normal ovaries 4. unexplained infertility 5. no endometriosis

Exclusion criteria

1 - poor responders to gonadotropin 2-Prior history of more than 3unsucceful ICSI 3-Any malformation of sexual organs

Design outcomes

Primary

Measure	Time frame	Description
Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients	9 months	Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients

Contacts

Primary ContactMarwa Ba Tarahony

marwatarahony9@gmail.com01008160037

Backup ContactKareem Ib Shaheen

01210966045

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026